Durability of Treatment Effect Using a Drug-Coated Balloon for Femoropopliteal Lesions
Authors:
Top Cited Papers
Open Access
- 1 December 2015
- Vol. 66 (21) , 2329-2338
Abstract
No abstract availableKeywords
Funding Information
- Medtronic
- Biotronik
This publication has 25 references indexed in Scilit:
- Sustained Safety and Effectiveness of Paclitaxel-Eluting Stents for Femoropopliteal LesionsJACC, 2013
- The Treatment of Femoropopliteal In-Stent RestenosisJACC, 2012
- Paclitaxel-Eluting Stents Show Superiority to Balloon Angioplasty and Bare Metal Stents in Femoropopliteal DiseaseCirculation: Cardiovascular Interventions, 2011
- Nitinol Stent Implantation Versus Balloon Angioplasty for Lesions in the Superficial Femoral Artery and Proximal Popliteal ArteryCirculation: Cardiovascular Interventions, 2010
- Inhibition of Restenosis in Femoropopliteal ArteriesCirculation, 2008
- Local Delivery of Paclitaxel to Inhibit Restenosis during Angioplasty of the LegNew England Journal of Medicine, 2008
- Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)Journal of Vascular Surgery, 2007
- Balloon Angioplasty versus Implantation of Nitinol Stents in the Superficial Femoral ArteryNew England Journal of Medicine, 2006
- Long-Segment SFA Stenting—The Dark Sides: In-Stent Restenosis, Clinical Deterioration, and Stent FracturesJournal of Endovascular Therapy, 2005
- Prevalence and clinical impact of stent fractures after femoropopliteal stentingJACC, 2005